Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chandan Das

Showing results (81-90 of 94) with videos related to

Pageof 10
Sort By:
International Journal of Biological Macromolecules|March 9, 2026
Hybrid nanogel system of quercetin-loaded squalene NLCs with zinc-HA network for dry eye syndromeAjit Mishra, Jitu Halder, Rakesh Kumar Sahoo, et al.
Current Pharmaceutical Design|October 27, 2025
Synthetic Polymer-Based Interventions in Wound Healing: A Clinical Perspective on their Efficacy and LimitationsDebasish Tripathy, Sudhanshu Ranjan Rout, Ivy Saha, et al.
The Journal of the Association of Physicians of India|July 18, 2019
A Multicentre, Open label, Randomized, Comparative, Parallel Group, Active-controlled, Phase III Clinical Trial to Evaluate Safety and Efficacy of Arbekacin Sulphate Injection versus Vancomycin Injection in Patients Diagnosed with MRSA InfectionAbhay Dube, Ashish Kumar Deb, Chandan Das, et al.
Journal of Ethnopharmacology|October 18, 2024
Protective effect of Tecoma stans (L.) Juss.ex Kunth in CFA-induced arthritic ratsChandan Das, Pritam Kar, Priyanka Dash, et al.
Journal of Drug Targeting|June 18, 2025
A novel mucoadhesive phytic acid grafted chitosan nanocarrier encapsulated with cisplatin for site-specific cervical cancer therapy: <i>in vitro</i> and <i>in vivo</i> assessmentsIvy Saha, Jitu Halder, Tushar Kanti Rajwar, et al.
AAPS Pharmscitech|March 28, 2025
Biogenic Amino Acid Cross-Linked Hyaluronic Acid Nanoparticles Containing Dexamethasone for the Treatment of Dry Eye SyndromeAjit Mishra, Jitu Halder, Ivy Saha, et al.
British Journal of Haematology|December 18, 2022
Long-term real-world outcomes of patients with acute promyelocytic leukaemia treated with arsenic trioxide and all-trans retinoic acid without chemotherapy-a retrospective, single-centre studyCharanpreet Singh, Uday Yanamandra, Parathan Karunakaran, et al.
International Journal of Pharmaceutics|March 12, 2025
Quercetin loaded biogenic squalene nano-lipid carriers for the treatment of dry eye syndromeAjit Mishra, Jitu Halder, Ivy Saha, et al.
Abdominal Radiology (New York)|November 16, 2023
Proposal for a new morphological "combined type" of gallbladder cancer: description of radiopathological characteristics and comparison with other morphological typesManika Chhabra, Daneshwari Kalage, Pankaj Gupta, et al.
Acta Oncologica (Stockholm, Sweden)|December 29, 2022
High-dose hydroxyurea with differentiating agents for treating ultra-high-risk acute promyelocytic leukemia in resource-challenged settingsCharanpreet Singh, Sarthak Wadhera, Uday Yanamandra, et al.
Pageof 10

Showing results (81-90 of 94) with videos related to

Sort By:
Pageof 10
International Journal of Biological Macromolecules|March 9, 2026
Hybrid nanogel system of quercetin-loaded squalene NLCs with zinc-HA network for dry eye syndromeAjit Mishra, Jitu Halder, Rakesh Kumar Sahoo, et al.
Current Pharmaceutical Design|October 27, 2025
Synthetic Polymer-Based Interventions in Wound Healing: A Clinical Perspective on their Efficacy and LimitationsDebasish Tripathy, Sudhanshu Ranjan Rout, Ivy Saha, et al.
The Journal of the Association of Physicians of India|July 18, 2019
A Multicentre, Open label, Randomized, Comparative, Parallel Group, Active-controlled, Phase III Clinical Trial to Evaluate Safety and Efficacy of Arbekacin Sulphate Injection versus Vancomycin Injection in Patients Diagnosed with MRSA InfectionAbhay Dube, Ashish Kumar Deb, Chandan Das, et al.
Journal of Ethnopharmacology|October 18, 2024
Protective effect of Tecoma stans (L.) Juss.ex Kunth in CFA-induced arthritic ratsChandan Das, Pritam Kar, Priyanka Dash, et al.
Journal of Drug Targeting|June 18, 2025
A novel mucoadhesive phytic acid grafted chitosan nanocarrier encapsulated with cisplatin for site-specific cervical cancer therapy: <i>in vitro</i> and <i>in vivo</i> assessmentsIvy Saha, Jitu Halder, Tushar Kanti Rajwar, et al.
AAPS Pharmscitech|March 28, 2025
Biogenic Amino Acid Cross-Linked Hyaluronic Acid Nanoparticles Containing Dexamethasone for the Treatment of Dry Eye SyndromeAjit Mishra, Jitu Halder, Ivy Saha, et al.
British Journal of Haematology|December 18, 2022
Long-term real-world outcomes of patients with acute promyelocytic leukaemia treated with arsenic trioxide and all-trans retinoic acid without chemotherapy-a retrospective, single-centre studyCharanpreet Singh, Uday Yanamandra, Parathan Karunakaran, et al.
International Journal of Pharmaceutics|March 12, 2025
Quercetin loaded biogenic squalene nano-lipid carriers for the treatment of dry eye syndromeAjit Mishra, Jitu Halder, Ivy Saha, et al.
Abdominal Radiology (New York)|November 16, 2023
Proposal for a new morphological "combined type" of gallbladder cancer: description of radiopathological characteristics and comparison with other morphological typesManika Chhabra, Daneshwari Kalage, Pankaj Gupta, et al.
Acta Oncologica (Stockholm, Sweden)|December 29, 2022
High-dose hydroxyurea with differentiating agents for treating ultra-high-risk acute promyelocytic leukemia in resource-challenged settingsCharanpreet Singh, Sarthak Wadhera, Uday Yanamandra, et al.
Pageof 10